Tesamorelin May Help HIV Patients Shed Fat

July 20, 2014 3:00 PM

4 0

MELBOURNE, Australia -- HIV-infected patients treated with a growth hormone releasing hormone analog achieved modest reductions in abdominal and liver fat, researchers said.

In a preliminary study that involved 54 patients, treatment with tesamorelin (Egrifta) reduced visceral adipose tissue 34 cm2 compared with a reduction of 8 cm2 achieved by patients on placebo (P=0.005), reported Steven Grinspoon, MD, of Harvard Medical School and Massachusetts General Hospital in B...

Read more

To category page